生长抑素及其受体在健康人与2型糖尿病患者肠道中的分布
本研究通过双气囊小肠镜采集12例2型糖尿病患者和12例年龄及BMI匹配的非糖尿病个体的肠道黏膜活检,分析生长抑素阳性细胞分布及生长抑素和SSTR1-5的mRNA表达谱。结果显示两组全肠道均有生长抑素阳性细胞,密度在小肠近端和直肠最高,与mRNA表达一致;SSTR1丰富表达,SSTR2、3、5低表达,SSTR4未检出,两组间无显著差异。
要点
- 生长抑素阳性细胞遍布全肠道,小肠近端和直肠密度最高。
- SSTR1 mRNA丰富表达,沿小肠递减,大肠均匀低表达。
- 2型糖尿病与健康对照组间细胞密度和mRNA表达无显著差异。
核心结论
- 生长抑素阳性细胞及生长抑素和SSTR1 mRNA在全人类肠道黏膜中丰富表达。
- 健康个体与2型糖尿病患者之间未观察到差异。
- SSTR2-5 mRNA表达水平低,SSTR4在人类肠道中未检出。
研究设计与样本
- 研究纳入12例2型糖尿病患者和12例年龄及体重指数匹配的非糖尿病个体。
- 通过双气囊小肠镜沿全小肠(间隔30 cm)及十二指肠、Treitz韧带、回盲部过渡区和大肠的7个解剖区域采集黏膜活检。
- 活检样本分析生长抑素阳性细胞及生长抑素和SSTR1-5的mRNA测序。
主要发现
- 两组全肠道均可见生长抑素阳性黏膜细胞,密度在小肠近端和直肠最高。
- 生长抑素mRNA表达谱与细胞密度分布一致。
- SSTR1 mRNA丰富表达,沿小肠递减,大肠均匀低表达。
- SSTR2、SSTR3和SSTR5 mRNA低水平表达,SSTR4 mRNA未检出。
- 两组间细胞密度或mRNA表达无显著差异。
临床怎么用
- 本研究提示生长抑素系统在全肠道分布广泛,SSTR1为主要受体亚型。
- 2型糖尿病患者肠道生长抑素系统表达与健康人无差异,不支持其作为主要病理生理差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Somatostatin is a peptide hormone exerting actions through 5 different somatostatin receptors (SSTR1-5). Somatostatin-positive cells have previously been found in intestinal mucosa and may be implicated in the pathophysiology of type 2 diabetes. Here, we characterized the distribution of somatostatin-positive cells and the mRNA expression profiles of somatostatin and SSTR1-5 along the intestinal tract of healthy individuals and patients with type 2 diabetes. METHODS: Mucosal biopsies were collected using double-balloon enteroscopy along the entire small intestine (with 30 cm intervals) and from 7 anatomically well-defined regions in the duodenum, at the Treitz ligament, at the ileocecal transition, and in the large intestine. Samples were collected from 12 patients with type 2 diabetes and 12 age- and body mass index-matched nondiabetic individuals. The biopsies were analyzed for somatostatin and mRNA sequencing of somatostatin and SSTR1-5. RESULTS: Somatostatin-positive mucosal cells were found throughout the intestinal tract in both groups with the highest density of cells in the proximal part of the small intestine and in the rectum, corresponding well with somatostatin mRNA expression profiles. SSTR1 was abundantly expressed with decreasing levels of mRNA along the small intestine and uniform, low expression through the large intestine. We detected low levels of SSTR2, SSTR3, and SSTR5 mRNA and no SSTR4 mRNA along the intestinal tract in both groups with no significant differences between groups for cell density or mRNA expression. CONCLUSIONS: Somatostatin-positive cells as well as somatostatin and SSTR1 mRNA expression are abundant in the mucosa through the entire human intestinal tract, and no differences between healthy individuals and patients with type 2 diabetes were observed. mRNA expression levels of SSTR2-5 are low and SSTR4 undetectable in the human intestinal tract.
引用
- Nielsen SW, Gilliam-Vigh H, Jorsal T, et al. Distribution of Somatostatin and Its Receptors in the Intestinal Tract in Healthy Patients and Patients with Type 2 Diabetes. J Clin Endocrinol Metab. 2026. PMID: 41379811. doi:10.1210/clinem/dgaf648
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。